Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICUCW) Shares Outstanding (Weighted Average) (2023 - 2025)

SeaStar Medical Holding's Shares Outstanding (Weighted Average) history spans 3 years, with the latest figure at $2.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 453.77% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $2.1 million, up 453.77%, while the annual FY2025 figure was $2.1 million, 453.77% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $2.1 million in Q4 2025 per ICUCW's latest filing, down from $11.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $13.0 million in Q1 2023 to a low of $374356.0 in Q4 2024.
  • Average Shares Outstanding (Weighted Average) over 3 years is $4.3 million, with a median of $2.7 million recorded in 2024.
  • The largest YoY upside for Shares Outstanding (Weighted Average) was 537.45% in 2024 against a maximum downside of 79.39% in 2024.
  • A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $866813.0 in 2023, then crashed by 56.81% to $374356.0 in 2024, then skyrocketed by 453.77% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Shares Outstanding (Weighted Average) are $2.1 million (Q4 2025), $11.3 million (Q2 2025), and $8.6 million (Q1 2025).